Options after progression on first-line CDK4/6 inhibitors in advanced breast cancer patients - Xiaomeng Jia; Kainan Wang; Xueqing Wang; Yiyang Luo; Huixin Liu; Zuowei Zhao; Jinbo Zhao; Man Li (Therapeutic Advances in Medical Oncology, 2025)